Resolutions from the Annual General Meeting of Novo Nordisk A/S
Bagsværd, Denmark, 23 March 2017 - Today, Novo Nordisk A/S held its Annual General Meeting, at which the following were adopted:
Financial year 2016 and 2017
-
The Company's statutory Annual Report 2016.
-
The actual remuneration of the Board of Directors for 2016 and the remuneration level for 2017.
Anzeige
The final dividend for 2016 of DKK 4.60 for each Novo Nordisk A or B share of DKK 0.20. The total dividend for 2016 of DKK 7.60 includes both the interim dividend of DKK 3.00 for each Novo
Nordisk A and B share of DKK 0.20 which were paid in August 2016 and a final dividend of DKK 4.60 for each Novo Nordisk A and B share of DKK 0.20 to be paid in March 2017.
Elections
-
Re-election of Göran Ando as chairman and Jeppe Christiansen as vice chairman of the Board of Directors.
-
Re-election of Brian Daniels, Sylvie Grégoire, Liz Hewitt and Mary Szela as members of the Board of Directors.
-
Election of Kasim Kutay and Helge Lund as new members of the Board of Directors.
-
Re-election of PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab as the Company's auditor.
Shares and capital
-
Reduction of the Company's B share capital by cancellation of part of the Company's own holding of B shares. The Company's B shares are reduced by DKK 10,000,000 from DKK 402,512,800 to DKK 392,512,800. The Company's A share capital of DKK 107,487,200 remains unchanged, whereby the Company's share capital will amount to DKK 500,000,000.
-
Authorisation to the Board of Directors to increase the Company's share capital.
-
Authorisation to the Board of Directors until the next Annual General Meeting to allow the Company to repurchase own shares of up to 10% of the share capital subject to a holding limit of 10% of the share capital.
Other
-
Revised Remuneration Principles were adopted.
-
Proposals from shareholders were not adopted.
Composition of the Board of Directors and its committees
After the Annual General Meeting, the Board of Directors held a board meeting to appoint members of its committees.
Lesen Sie auch
The Board of Directors decided at the same time to establish a temporary Research & Development Committee in light of the recently updated research and development strategy and priorities. The Research & Development Committee will assist the Board of Directors with oversight of the research and development strategy, the pipeline and other tasks.
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
1 im Artikel enthaltener WertIm Artikel enthaltene Werte